Long-term, life, and disability insurers may still be able to deny coverage to patients with a genetic disease, under current nondiscrimination legislation.
Advertisement
The Scientist
Most Recent
The US Food and Drug Administration approves the first flu vaccine made from recombinant proteins rather than a weakened virus.
Fecal transplants outcompeted traditional antibiotics at curing a deadly intestinal infection.
A neurodegenerative disease researcher found guilty of fabricating results in funding applications has written an open letter of apology and clarification.
Scientists use virus-free gene therapy on patient-derived stem cells to repair spinal muscular atrophy in mice.
Researchers and biotech companies are bringing a universal flu vaccine closer to reality.
An NIH study finds that the former NFL linebacker who committed suicide last May had signs of degenerative brain disease.
A drug applied to the ears of deaf mice has prompted the regrowth of noise-damaged hair cells and resulted in slight improvements in the animals’ hearing.
Resource-limited countries are in desperate need of better diagnostic tests for life-threatening illnesses.
Transplanting synthetic stool made of beneficial microbes cures deadly diarrheal infections in two patients.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
